Document is current
Any future updates will be listed below
-
Authors
Galaverna, Federica https://orcid.org/0000-0003-0717-2924
Styczynski, Jan https://orcid.org/0000-0002-3158-119X
Ljungman, Per https://orcid.org/0000-0002-8281-3245
- License Information
-
More Information
Article History
Received: 24 February 2025
Revised: 23 September 2025
Accepted: 13 October 2025
First Online: 22 October 2025
Competing interests
: JS served as a consultant, speaker, or scientific advisor for MSD. PL has served as a consultant and speaker for MSD, a consultant and speaker for Moderna, and a consultant for Anocca Pharmaceuticals, and Takeda on CMV. FG reported no potential conflicts.
